Skip to main content
SpringerLink
Log in

Characteristics and utilization patterns of needle-exchange attendees in Chicago: 1994–1998

  • Original Articles: Substance Use and HIV Prevention
  • Published:
Journal of Urban Health Aims and scope Submit manuscript

Abstract

The objectives of this study were to describe characteristics and utilization patterns of participants attending a needle-exchange program (NEP) in Chicago, Illinois. Since 1994, demographics of NEP attendees and program utilization data were collected systematically at 22 sites operated by the Chicago Recovery Alliance (CRA). Descriptive statistics were used to assess time trends, site variations, and characteristics of attendees in day sites versus evening sites. A total of 11,855 injection drug users (IDUs) visited the NEP at least once from 1994 to 1998. Median age was 41 years, and 74% were male. Overall race distribution was African-American 50%, Caucasian 38%, Puerto Rican 10%, other 2%. Over time, there was a proportional decrease in African-American users (55.4% to 39.9%,P<.001), a significant increase in Puerto Rican users (1.4% to 14.1%,P<.001), and a stable proportion of Caucasian users (42%). Each year, 15–20% of all clients were first-time attenders. Overall, participants attending evening versus day sites were younger (median age 39 years vs. 42 years,P<.001) and more ethnically diverse. Over a 4-year period, this NEP reached a diverse population of IDUs and recruited a stable proportion of first-time users. Compared to daytime NEP venues, evening NEP sites attracted younger clients and those who were more diverse ethnically. To maximize coverage of sterile syringes, NEPs should strive for diversification in terms of hours of operation and location.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Schwartz RH. Syringe and needle exchange programs: Part I.South Med. J. 1993;86(3): 318–322.

    CAS  PubMed  Google Scholar 

  2. Des Jarlais DC, Friedman SR, Hopkins W. Risk reduction for the acquired immunodeficiency syndrome among intravenous drug users.Ann Intern Med. 1985;103(5):755–759.

    PubMed  Google Scholar 

  3. Normand J, Vlahov D, Moses LE.Preventing HIV Transmission: the Role of Sterile Needles and Bleach. Washington, DC: National Academy Press; 1995.

    Google Scholar 

  4. Strathdee SA, van Ameijden EJ, Mesquita F, Wodak A, Rana S, Vlahov D. Can HIV epidemics among injection drug users be prevented?AIDS. 1998;12(suppl A):S71-S79.

    PubMed  Google Scholar 

  5. Holmberg SD. The estimated prevalence and incidence of HIV in 96 large US metropolitan areas.Am J Public Health. 1996;86(5):642–654.

    CAS  PubMed  Google Scholar 

  6. van Ameijden EJC, Watters JK, van den Hoek JAR, Coutinho RA. Interventions among injecting drug users: do they work?AIDS. 1995;9(suppl A):S75-S84.

    PubMed  Google Scholar 

  7. Des Jarlais DC, Hagan H, Friedman SR, et al. Maintaining low HIV seroprevalence in populations of injecting drug users.JAMA. 1995;274(15):1226–1231.

    PubMed  Google Scholar 

  8. Des Jarlais DC, Friedman SR, Friedmann P, et al. HIV/AIDS-related behavior change among injecting drug users in different national settings.AIDS. 1995;9(6):611–617.

    PubMed  Google Scholar 

  9. Des Jarlais DC, Marmor M, Paone D, et al. HIV incidence among injecting drug users in New York City syringe-exchange programmes.Lancet. 1996;348(9033):987–991.

    Article  PubMed  Google Scholar 

  10. Vlahov D, Junge B. The role of needle exchange programs in HIV prevention.Public Health Rep. 1998;113(suppl 1):75–80.

    PubMed  Google Scholar 

  11. Hagan H, Jarlais DC, Friedman SR, Purchase D, Alter MJ. Reduced risk of hepatitis B and hepatitis C among injection drug users in the Tacoma syringe exchange program.Am J Public Health. 1995;85(11):1531–1537.

    CAS  PubMed  Google Scholar 

  12. Broadhead RS, van Hulst Y, Heckathorn DD. The impact of a needle exchange's closure.Public Health Rep. 1999;114(5):439–447.

    Article  CAS  PubMed  Google Scholar 

  13. Lurie P, Drucker E. An opportunity lost: HIV infections associated with lack of a national needle-exchange programme in the USA.Lancet. 1997;349(9052):604–608.

    Article  CAS  PubMed  Google Scholar 

  14. Guydish J, Bucardo J, Young M, Woods W, Grinstead O, Clark W. Evaluating needle exchange: are there negative effects?AIDS. 1993;7(6):871–876.

    CAS  PubMed  Google Scholar 

  15. Schoenbaum EE, Hartel DM, Gourevitch MN. Needle exchange use among a cohort of injecting drug users.AIDS. 1996;10(14):1729–1734.

    CAS  PubMed  Google Scholar 

  16. Bluthenthal RN, Kral AH, Gee L, Erringer EA, Edlin BR. The effect of syringe exchange use on high-risk injection drug users: a cohort study.AIDS. 2000;14(5):605–611.

    CAS  PubMed  Google Scholar 

  17. Vlahov D, Junge B, Brookmeyer R, et al. Reductions in high-risk drug use behaviors among participants in the Baltimore needle exchange program.J Acquir Immune Defic Syndr Hum Retrovirol. 1997;16(5):400–406.

    CAS  PubMed  Google Scholar 

  18. Heimer R, Khoshnood K, Bigg D, Guydish J, Junge B. Syringe use and reuse: effects of syringe exchange programs in four cities.J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(suppl 1):S37-S44.

    PubMed  Google Scholar 

  19. Paone D, Clark J, Shi Q Purchase D, Des Jarlais DC. Syringe exchange in the United States, 1996: a national profile.Am J Public Health. 1999;89(1):43–46.

    CAS  PubMed  Google Scholar 

  20. Strathdee SA, Celentano DD, Shah N, et al. Needle-exchange attendance and health care utilization promote entry into detoxification.J Urban Health. 1999;76(4):448–460.

    Article  CAS  PubMed  Google Scholar 

  21. Heimer R. Can syringe exchange serve as a conduit to substance abuse treatment?J Subst Abuse Treat. 1998;15(3):183–191.

    Article  CAS  PubMed  Google Scholar 

  22. Somlai AM, Kelly JA, Otto-Salaj L, Nelson D. “Lifepoint”: a case study in using social science community identification data to guide the implementation of a needle exchange program.AIDS Educ Prev. 1999;11(3):187–202.

    CAS  PubMed  Google Scholar 

  23. Centers for Disease Control and Prevention, Health Resources and Services Administration, National Institute on Drug Abuse, Substance Abuse and Mental Health Services Administration.HIV Prevention Bulletin: Medical Advice for Persons Who Inject Illicit Drugs. Baltimore, MD: US Department of Health and Human Services; 1997.

    Google Scholar 

  24. Drucker E, Lurie P, Wodak A, Alcabes P. Measuring harm reduction: the effects of needle and syringe exchange programs and methadone maintenance on the ecology of HIV.AIDS. 1998;12(suppl A):S217-S230.

    PubMed  Google Scholar 

  25. Rockwell R, Des Jarlais DC, Friedman SR, Perlis TE, Paone D. Geographic proximity, policy and utilization of syringe exchange programmes.AIDS Care. 1999;11(4):437–442.

    Article  CAS  PubMed  Google Scholar 

  26. Keene J, Stimson GV, Jones S, Parry-Langdon N. Evaluation of syringe-exchange for HIV prevention among injecting drug users in rural and urban areas of Wales.Addiction. 1993;88(8):1063–1070.

    Article  CAS  PubMed  Google Scholar 

  27. Khoshnood K, Kaplan EH, Heimer R. “Dropouts” or “drop-ins”? Client retention and participation in New Haven's needle exchange program.Public Health Rep. 1995;110(4): 462–466.

    CAS  PubMed  Google Scholar 

  28. Kipke MD, Unger JB, Palmer RF, Edgington R. Drug use, needle sharing, and HIV risk among injection drug-using street youth.Subst Use Missue. 1996;31(9):1167–1187.

    CAS  Google Scholar 

  29. Anderson JE, Cheney R, Clatts M, et al. HIV risk behavior, street outreach, and condom use in eight high-risk populations.AIDS Educ Prev. 1996;8(3):191–204.

    CAS  PubMed  Google Scholar 

  30. Cassin S, Geoghegan T, Cox G. Young injectors: a comparative analysis of risk behaviour.Ir J Med Sci. 1998;167(4):234–237.

    CAS  PubMed  Google Scholar 

  31. Battjes RJ, Leukefeld CG, Pickens RW. Age at first injection and HIV risk among intravenous drug users.Am J Drug Alcohol Abuse. 1992;18(3):263–273.

    CAS  PubMed  Google Scholar 

  32. Vlahov D, Munoz A, Anthony JC, Cohn S, Celentano DD, Nelson KE. Association of drug injection patterns with antibody to human immunodeficiency virus type 1 among intravenous drug users in Baltimore, Maryland.Am J Epidemiol. 1990;132(5):847–856.

    CAS  PubMed  Google Scholar 

  33. Rich JD, Strong L, Towe CW, McKenzie M. Obstacles to needle exchange participation in Rhode Island.J Acquir Immune Defic Syndr Hum Retrovirol. 1999;21(5):396–400.

    CAS  Google Scholar 

  34. Guydish J, Bucardo J, Clark G, Bernheim S. Evaluating needle exchange: a description of client characteristics, health status, program utilization, and HIV risk behavior.Subst Use Misuse. 1998;33(5):1173–1196.

    CAS  PubMed  Google Scholar 

  35. Garfein RS, Doherty MC, Monterroso ER, Thomas DL, Nelson KE, Vlahov D. Prevalence and incidence of hepatitis C virus infection among young adult injection drug users.J Acquir Immune Defic Syndr Hum Retrovirol. 1998;18(suppl 1):S11-S19.

    PubMed  Google Scholar 

  36. Centers for Disease Control and Prevention.HIV Surveillance Reports: 1994–1998. Atlanta, GA: Centers for Disease Control and Prevention; 1999;6–11.

    Google Scholar 

  37. Junge B, Vlahov D, Riley E, Huettner S, Brown M, Beilenson P. Pharmacy access to sterile syringes for injection drug users: attitudes of participants in a syringe exchange program.J Am Pharm Assoc (Wash). 1999;39(1):17–22.

    CAS  Google Scholar 

  38. Riley E, Safaeian M, Strathdee SA, et al. Comparing new participants of a mobile versus pharmacy-based needle exchange program.J Acquir Immune Defic Syndr Hum Retrovirol. In press.

  39. Friedman SR, Curtis R, Jose B, Flom PL, Neaigus A, Des J. The message not heard: myth and reality in discussions about syringe exchange.AIDS. 1999;13(6):738–739.

    Article  CAS  PubMed  Google Scholar 

  40. Heimer R, Bluthenthal RN, Singer M, Khoshnood K. Structural impediments to operational syringe-exchange programs.AIDS Public Policy J. 1996;11(4):169–184.

    CAS  PubMed  Google Scholar 

  41. Schwartz RH. Syringe and needle exchange programs worldwide: Part II.South Med J. 1993;86(3):323–327.

    CAS  PubMed  Google Scholar 

  42. Bluthenthal RN, Kral AH, Erringer EA, Edlin BR. Use of an illegal syringe exchange and injection-related risk behaviors among street-recruited injection drug users in Oakland, California, 1992 to 1995.J Acquir Immune Defic Syndr Hum Retrovirol. 1998; 18(5):505–511.

    CAS  PubMed  Google Scholar 

  43. Bluthenthal RN, Kral AH, Lorvick J, Watters JK. Impact of law enforcement on syringe exchange programs: a look at Oakland and San Francisco.Med Anthropol. 1997;18(1): 61–83.

    CAS  PubMed  Google Scholar 

  44. Wiebel WW, Jimenez A, Johnson W, et al. Risk behavior and HIV seroincidence among out-of-treatment injection drug users: a four-year prospective study.J Acquir Immune Defic Syndr Hum Retrovirol. 1996;12(3):282–289.

    CAS  PubMed  Google Scholar 

  45. Burris S, Finucane D, Gallagher H, Grace J. The legal strategies used in operating syringe exchange programs in the United States.Am J Public Health. 1996;86(8, pt 1): 1161–1166.

    CAS  PubMed  Google Scholar 

  46. Des J, Hagan H, Friedman SR, et al. Maintaingng low HIV seroprevalence in populations of injecting drug users.JAMA. 1995;274(15):1226–1231.

    Google Scholar 

  47. Vlahov D, Ryan C, Solomon L, Cohn S, Holt MR, Akhter MN. A pilot syringe exchange program in Washington, DC.Am J Public Health. 1994;84(2):303–304.

    CAS  PubMed  Google Scholar 

  48. Obadia Y, Feroni I, Perrin V, Vlahov D, Moatti JP. Syringe vending machines for injection drug users: an experiment in Marseille, France.Am J Public Health. 1999;89(12): 1852–1854.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Johns Hopkins University School of Hygiene and Public Health, Baltimore, Maryland

    Heena Brahmbhatt MPH &  Steffanie A. Strathdee PhD (Associate Professor)

  2. Chicago Recovery Alliance, Chicago, Illinois

    Dan Bigg

Authors
  1. Heena Brahmbhatt MPH
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Dan Bigg
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Steffanie A. Strathdee PhD
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Steffanie A. Strathdee PhD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Brahmbhatt, H., Bigg, D. & Strathdee, S.A. Characteristics and utilization patterns of needle-exchange attendees in Chicago: 1994–1998. J Urban Health 77, 346–358 (2000). https://doi.org/10.1007/BF02386745

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02386745

Key words

Search

Navigation